Role of delay discounting in predicting change in HBA1c for individuals with prediabetes
- 22-03-2019
- Auteurs
- Leonard H. Epstein
- Rocco A. Paluch
- Jeff S. Stein
- Alexandra M. Mellis
- Teresa Quattrin
- Lucy D. Mastrandrea
- Kyle A. Bree
- Mark H. Greenawald
- Warren K. Bickel
- Gepubliceerd in
- Journal of Behavioral Medicine | Uitgave 5/2019
Abstract
The majority of people with prediabetes transition to type 2 diabetes. Weight gain is a known predictor of increasing the risk of diabetes, but another reason may be a focus on immediate rewards and discounting of the future. Delay discounting (DD: devaluation of future consequences) is related to obesity and poor glycemic control in persons with type 2 diabetes. This study was designed to assess whether changes in DD are associated with HbA1c change beyond BMI change in individuals with prediabetes. Hierarchical regression showed changes in BMI (p = 0.008) and the $1000 DD task (p = 0.04) were associated with HbA1c change beyond demographic characteristics, with the full model accounting for 25.8% of the variance. Those with greater BMI increases and greater increases in discounting of the future showed the greatest increases in HbA1c. DD represents a novel target to prevent progression from prediabetes to type 2 diabetes.
- Titel
- Role of delay discounting in predicting change in HBA1c for individuals with prediabetes
- Auteurs
-
Leonard H. Epstein
Rocco A. Paluch
Jeff S. Stein
Alexandra M. Mellis
Teresa Quattrin
Lucy D. Mastrandrea
Kyle A. Bree
Mark H. Greenawald
Warren K. Bickel
- Publicatiedatum
- 22-03-2019
- Uitgeverij
- Springer US
- Gepubliceerd in
-
Journal of Behavioral Medicine / Uitgave 5/2019
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521 - DOI
- https://doi.org/10.1007/s10865-019-00026-3
Deze inhoud is alleen zichtbaar als je bent ingelogd en de juiste rechten hebt.